Inflammatory Demyelinating Polyneuropathy
📧 Sign up to get email alerts when something new happens for Inflammatory Demyelinating Polyneuropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: NT-3 Levels and Function in Individuals With CMT
A clinical trial update examining NT-3 levels and function in individuals with Charcot-Marie-Tooth disease; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating BAFF-R CAR-T cell therapy for refractory neuroimmune diseases is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients [Phase 3]
Phase 3 clinical trial evaluating safety and efficacy of different PANZYGA dose regimens in pediatric chronic inflammatory demyelinating pol…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Vitaccess Real CIDP Registry
This entry reports a real-world Vitaccess registry study for chronic inflammatory demyelinating polyneuropathy (CIDP). The study is currentl…
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: Biorepository and Registry for Plasma Exchange Patients
A clinical trial update announcing a biorepository and registry for patients undergoing plasma exchange, with recruiting status and listed i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-04-20Clinical Trial Update: Clinical Trial to Assess the Safety of a Novel Scaffold Biomaterial [NA]
This entry reports an active-not-recruiting Mayo Clinic clinical trial assessing the safety of a novel scaffold biomaterial in patients with…
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: Polyneuropathy, Impairments and Physical Activity - The PolyImPAct Study
A clinical trial update for the PolyImPAct study investigating polyneuropathy, impairments, and physical activity, currently recruiting and …
-
CLINICAL_TRIALS research · 2025-03-05Clinical Trial Update: Ripertamab for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy [Phase 3]
A Phase 3 clinical trial evaluating Ripertamab for chronic inflammatory demyelinating polyneuropathy is currently not recruiting.
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Exploratory Study on Predicting CIDP Patients' Decline During IV Immunoglobulin Treatment Adaptation Feasibility.
An exploratory study evaluating the feasibility of predicting decline in chronic inflammatory demyelinating polyneuropathy patients during a…
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: Hizentra® in Inflammatory Neuropathies - pHeNIx Study
A pHeNIx clinical trial is evaluating Hizentra for Chronic Inflammatory Demyelinating Polyneuropathy and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-01-01Clinical Trial Update: Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System. [EARLY_Phase 1]
A Phase 1 trial evaluating universal CAR-T cells for refractory autoimmune diseases of the nervous system; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: Immunoadsorption Versus Immunoglobulins for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) [Phase 2]
A Phase 2 study comparing immunoadsorption with intravenous immunoglobulin for chronic inflammatory demyelinating polyrneuropathy (CIDP) is …
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: Rituximab Induced Remission in Patients With Chronic Inflammatory Demyelinating Polyneuropathy [Phase 3]
Phase 3 clinical trial evaluating rituximab for inducing remission in chronic inflammatory demyelinating polyneuropathy is currently recruit…
-
CLINICAL_TRIALS research · 2024-10-30Clinical Trial Update: Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System [EARLY_Phase 1]
An early-phase clinical trial is investigating CT103A cell therapy for relapsed/refractory antibody-associated inflammatory diseases of the …
-
CLINICAL_TRIALS research · 2024-05-17Clinical Trial Update: Subcutaneous Immunoglobulin in De-novo CIDP (SIDEC) [Phase 4]
A Phase 4 clinical trial (SIDEC) is evaluating subcutaneous immunoglobulin for de novo Chronic Inflammatory Demyelinating Polyneuropathy. Th…
-
CLINICAL_TRIALS research · 2017-05-25Clinical Trial Update: Panzyga in CIDP Administered at Different Infusion Rates [Phase 3]
A Phase 3 clinical trial update evaluating Panzyga for chronic inflammatory demyelinating polyneuropathy at different infusion rates.
-
CLINICAL_TRIALS research · 2016-11-11Clinical Trial Update: IVIg for Demyelination in Diabetes Mellitus [Phase 4]
A Phase 4 clinical trial update evaluating intravenous immunoglobulin (IVIg) for demyelinating peripheral neuropathies in diabetes mellitus,…
-
CLINICAL_TRIALS research · 2016-05-16Clinical Trial Update: sCD163 & CD19 as Candidate Biomarkers in CIDP and MMN
A clinical trial update investigates whether sCD163 and CD19 could serve as biomarkers for Chronic Inflammatory Demyelinating Polyneuropathy…
-
CLINICAL_TRIALS research · 2016-05-12Clinical Trial Update: Effect of Resistance and Aerobic Exercise in CIDP or MMN [NA]
A completed clinical trial evaluating the effects of resistance and aerobic exercise in chronic inflammatory demyelinating polyneuropathy an…
-
CLINICAL_TRIALS research · 2011-11-10Clinical Trial Update: Perception and Multisensory Integration in Neurological Patients Using fMRI [NA]
An update on a brain-imaging clinical study investigating perception and multisensory integration in neurological patients using fMRI across…